Law360, New York (June 06, 2005, 12:00 AM ET) -- Swiss drug maker Roche and licensee Allergan Inc. have sued Canadian generics maker Apotex in a California federal court over its plans to make a generic version of the eye-inflammation treatment Acular.
The complaint, filed by Roche Palo Alto LLC and Allergan, was filed shortly after the U.S. Court of Appeals for the Federal Circuit granted Apotex a second chance to seek the invalidation of a patent for Acular.
Apotex filed an abbreviated new drug application with the U.,S. Food and Drug Administration for Acular with...
Roche, Allergan Sue Apotex Again Over Acular Patent
To view the full article, take a free trial now.
